NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression

Cancer cells respond differently to inhibitors of Poly (ADP-ribose) polymerase. Here the authors reveal that ovarian cancer cells with higher cellular NADP+ levels are more sensitive to clinically relevant PARP1 inhibitors and show that NADP+ act as an endogenous inhibitor of PARP enzymes.

Guardado en:
Detalles Bibliográficos
Autores principales: Chunjing Bian, Chao Zhang, Tao Luo, Aditi Vyas, Shih-Hsun Chen, Chao Liu, Muzaffer Ahmad Kassab, Ying Yang, Mei Kong, Xiaochun Yu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/5bbffa525898454999e7e01354382c95
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5bbffa525898454999e7e01354382c95
record_format dspace
spelling oai:doaj.org-article:5bbffa525898454999e7e01354382c952021-12-02T16:57:41ZNADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression10.1038/s41467-019-08530-52041-1723https://doaj.org/article/5bbffa525898454999e7e01354382c952019-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-08530-5https://doaj.org/toc/2041-1723Cancer cells respond differently to inhibitors of Poly (ADP-ribose) polymerase. Here the authors reveal that ovarian cancer cells with higher cellular NADP+ levels are more sensitive to clinically relevant PARP1 inhibitors and show that NADP+ act as an endogenous inhibitor of PARP enzymes.Chunjing BianChao ZhangTao LuoAditi VyasShih-Hsun ChenChao LiuMuzaffer Ahmad KassabYing YangMei KongXiaochun YuNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Chunjing Bian
Chao Zhang
Tao Luo
Aditi Vyas
Shih-Hsun Chen
Chao Liu
Muzaffer Ahmad Kassab
Ying Yang
Mei Kong
Xiaochun Yu
NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
description Cancer cells respond differently to inhibitors of Poly (ADP-ribose) polymerase. Here the authors reveal that ovarian cancer cells with higher cellular NADP+ levels are more sensitive to clinically relevant PARP1 inhibitors and show that NADP+ act as an endogenous inhibitor of PARP enzymes.
format article
author Chunjing Bian
Chao Zhang
Tao Luo
Aditi Vyas
Shih-Hsun Chen
Chao Liu
Muzaffer Ahmad Kassab
Ying Yang
Mei Kong
Xiaochun Yu
author_facet Chunjing Bian
Chao Zhang
Tao Luo
Aditi Vyas
Shih-Hsun Chen
Chao Liu
Muzaffer Ahmad Kassab
Ying Yang
Mei Kong
Xiaochun Yu
author_sort Chunjing Bian
title NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
title_short NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
title_full NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
title_fullStr NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
title_full_unstemmed NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
title_sort nadp+ is an endogenous parp inhibitor in dna damage response and tumor suppression
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/5bbffa525898454999e7e01354382c95
work_keys_str_mv AT chunjingbian nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
AT chaozhang nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
AT taoluo nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
AT aditivyas nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
AT shihhsunchen nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
AT chaoliu nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
AT muzafferahmadkassab nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
AT yingyang nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
AT meikong nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
AT xiaochunyu nadpisanendogenousparpinhibitorindnadamageresponseandtumorsuppression
_version_ 1718382502550175744